Download PDF
Semin Vasc Med 2005; 5(2): 110-123
DOI: 10.1055/s-2005-872397
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA.

Dietary Determinants of Plasma Homocysteine Concentrations

Petra Verhoef1 , 2 , Lisette C.P.G. M. de Groot1
  • 1Division of Human Nutrition, Wageningen University, Nutrition and Health Programme, Wageningen, The Netherlands
  • 2Wageningen Centre for Food Sciences, Nutrition and Health Programme, Wageningen, The Netherlands
Further Information

Publication History

Publication Date:
27 July 2005 (online)

    Permissions and Reprints

ABSTRACT

Severe hyperhomocysteinemia is typically caused by rare enzymatic defects or by renal failure. In contrast, mild to moderate hyperhomocysteinemia chiefly results from suboptimal status of nutritional factors involved in homocysteine metabolism. Low dietary intake of folate is the most important nutritional cause of elevated homocysteine (tHcy) concentrations. Folic acid is more effective than dietary folate in lowering tHcy concentrations, and a daily dose of 400 μg of folic acid is the minimum daily dose associated with the maximum tHcy-lowering effect (∼20-25% reduction). Mean fasting tHcy concentrations have dropped substantially in populations with mandatory folic acid fortification, and other B-vitamins, such as vitamin B12, are important determinants of tHcy levels in this setting. Vitamins B2 and B6 have little influence on fasting tHcy concentrations, although the former may be relevant in individuals with the MTHFR 677 TT-genotype, and the latter may improve tHcy catabolism in elderly individuals. Betaine and choline can lower fasting tHcy concentrations to a similar extent as folic acid, particularly in the setting of a high intake of methionine. Consumption of tea and coffee increase tHcy concentrations by up to 20%. A high-protein meal also increases tHcy, but these changes are transient, and levels return to normal after an overnight fast. Serine and cystine also influence the methionine-induced postprandial rise in tHcy concentrations. In conclusion, alteration in dietary intake or use of folic acid supplements can substantially lower tHcy concentrations. However, it is not known whether lowering tHcy levels can reduce the risk of cardiovascular disease or cognitive decline or prevent pregnancy complications or osteoporosis.

KEYWORDS

Plasma total homocysteine - B vitamins - dietary habits - supplement use

REFERENCES

1 Throughout this article, “folic acid” refers to the oxidized form of the vitamin, as used in supplements and food fortification, whereas “folate” refers to all vitamers, either in blood, tissue, or food.

  • 1 Yap S. Classical homocystinuria: vascular risk and its prevention.  J Inherit Metab Dis. 2003;  26 259-265
    CrossrefPubMedGoogle Scholar
  • 2 Nelen W L. Hyperhomocysteinaemia and human reproduction.  Clin Chem Lab Med. 2001;  39 758-763
    CrossrefPubMedGoogle Scholar
  • 3 The Homocysteine Studies Collaboration . Homocysteine and risk of ischemic heart disease and stroke.  JAMA. 2002;  288 2015-2022
    CrossrefPubMedGoogle Scholar
  • 4 Seshadri S, Beiser A, Selhub J et al.. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease.  N Engl J Med. 2002;  346 476-483
    CrossrefPubMedGoogle Scholar
  • 5 McLean R R, Jacques P F, Selhub J et al.. Homocysteine as a predictive factor for hip fracture in older persons.  N Engl J Med. 2004;  350 2042-2049
    CrossrefPubMedGoogle Scholar
  • 6 van Meurs J B, Dhonukshe-Rutten R A, Pluijm S M et al.. Homocysteine levels and the risk of osteoporotic fracture.  N Engl J Med. 2004;  350 2033-2041
    CrossrefPubMedGoogle Scholar
  • 7 Verhoef P, Katan M B. A healthy lifestyle lowers homocysteine, but should we care? Editorial.  Am J Clin Nutr. 2004;  79 713-714
    PubMedGoogle Scholar
  • 8 Selhub J, Jacques P F, Wilson P W, Rush D, Rosenberg I H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.  JAMA. 1993;  270 2693-2698
    CrossrefPubMedGoogle Scholar
  • 9 Shimakawa T, Nieto F J, Malinow M R, Chamless L E, Schreiner P J, Szklo M. Vitamin intake: a possible determinant of plasma homocysteine among middle-aged adults.  Ann Epidemiol. 1997;  7 285-293
    CrossrefPubMedGoogle Scholar
  • 10 Jacques P F, Bostom A G, Wilson P W, Rich S, Rosenberg I H, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.  Am J Clin Nutr. 2001;  73 613-621
    PubMedGoogle Scholar
  • 11 Bates C J, Mansoor M A, Gregory J, Pentiev K, Prentice A. Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over.  Br J Nutr. 2002;  87 71-79
    CrossrefPubMedGoogle Scholar
  • 12 van Asselt D Z, de Groot L C, van Staveren W A et al.. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects.  Am J Clin Nutr. 1998;  68 328-334
    PubMedGoogle Scholar
  • 13 Clarke R, Woodhouse P, Ulvik A et al.. Variability and determinants of total homocysteine concentrations in plasma in an elderly population.  Clin Chem. 1998;  44 102-107
    PubMedGoogle Scholar
  • 14 Koehler K M, Romero L J, Stauber P M et al.. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women.  J Am Coll Nutr. 1996;  15 364-376
    PubMedGoogle Scholar
  • 15 de Bree A, Verschuren W M, Blom H J, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y.  Am J Clin Nutr. 2001;  73 1027-1033
    PubMedGoogle Scholar
  • 16 Booth G L, Wang E E. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.  CMAJ. 2000;  163 21-29
    PubMedGoogle Scholar
  • 17 Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' collaboration.  BMJ. 1998;  22 400-898
    PubMedGoogle Scholar
  • 18 Earnest C P, Wood K A, Church T S. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation.  J Am Coll Nutr. 2003;  22 400-407
    PubMedGoogle Scholar
  • 19 Lewerin C, Nilsson-Ehle H, Matousek M, Lindstedt G, Steen B. Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial.  Eur J Clin Nutr. 2003;  57 1426-1436
    CrossrefPubMedGoogle Scholar
  • 20 McKay D L, Perrone G, Rasmussen H, Dallal G, Blumberg J B. Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet.  J Nutr. 2000;  130 3090-3096
    PubMedGoogle Scholar
  • 21 Quinlivan E P, McPartlin J, McNulty H et al.. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.  Lancet. 2002;  359 227-228
    CrossrefPubMedGoogle Scholar
  • 22 Tapola N S, Karvonen H M, Niskanen L K, Sarkkinen E S. Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women.  Eur J Clin Nutr. 2004;  58 376-385
    CrossrefPubMedGoogle Scholar
  • 23 Tucker K L, Olson B, Bakun P, Dallal G E, Selhub J, Rosenberg I H. Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial.  Am J Clin Nutr. 2004;  79 805-811
    PubMedGoogle Scholar
  • 24 Wolters M, Hermann S, Hahn A. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.  Eur J Nutr. 2005;  44 183-192
    CrossrefPubMedGoogle Scholar
  • 25 Aisen P S, Egelko S, Andrews H et al.. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease.  Am J Geriatr Psychiatry. 2003;  11 246-249
    PubMedGoogle Scholar
  • 26 Bleie O, Refsum H, Ueland P M et al.. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.  Am J Clin Nutr. 2004;  80 641-648
    PubMedGoogle Scholar
  • 27 de Jong N, Chin A, Paw M J et al.. Nutrient-dense foods and exercise in frail elderly: effects on B vitamins, homocysteine, methylmalonic acid, and neuropsychological functioning.  Am J Clin Nutr. 2001;  73 338-346
    PubMedGoogle Scholar
  • 28 Lee B J, Huang M C, Chung L J et al.. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.  Eur J Clin Nutr. 2004;  58 481-487
    CrossrefPubMedGoogle Scholar
  • 29 Lehmann M, Regland B, Blennow K, Gottfries C G. Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment.  Dement Geriatr Cogn Disord. 2003;  16 145-150
    CrossrefPubMedGoogle Scholar
  • 30 Lobo A, Naso A, Arheart K et al.. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12.  Am J Cardiol. 1999;  83 821-825
    CrossrefPubMedGoogle Scholar
  • 31 Schnyder G, Roffi M, Flammer Y, Pin R, Hess O M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.  JAMA. 2002;  288 973-979
    CrossrefPubMedGoogle Scholar
  • 32 Toole J F, Malinow M R, Chambless L E et al.. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.  JAMA. 2004;  291 565-575
    CrossrefPubMedGoogle Scholar
  • 33 Clarke R, Harrison G, Richards S. Vital Trial Collaborative Group . Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia.  J Intern Med. 2003;  254 67-75
    CrossrefPubMedGoogle Scholar
  • 34 Rader J I. Folic acid fortification, folate status and plasma homocysteine.  J Nutr. 2002;  132 2466S-2470S
    PubMedGoogle Scholar
  • 35 McNulty H, Ward M, Pentieva K et al.. Dietary strategies to lower plasma homocysteine concentrations. Faseb Summer Research Conference, Folic acid, Vitamin B12, and One Carbon Metabolism Snowmass Village, Colorado; 2004
    Google Scholar
  • 36 Brouwer I A, van Dusseldorp M, West C E, Steegers-Theunissen R PM. Bioavailability and bioefficacy of folate and folic acid in humans.  Nutritional Research Reviews. 2001;  14 267-293
    PubMedGoogle Scholar
  • 37 Brouwer I A, van Dusseldorp M, West C E et al.. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial.  J Nutr. 1999;  129 1135-1139
    PubMedGoogle Scholar
  • 38 Venn B J, Mann J I, Williams S M et al.. Dietary counseling to increase natural folate intake: a randomized, placebo-controlled trial in free-living subjects to assess effects on serum folate and plasma total homocysteine.  Am J Clin Nutr. 2002;  76 758-765
    PubMedGoogle Scholar
  • 39 Broekmans W M, Klopping-Ketelaars I A, Schuurman C R et al.. Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans.  J Nutr. 2000;  130 1578-1583
    PubMedGoogle Scholar
  • 40 Daly S, Mills J L, Molloy A M et al.. Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age.  QJM. 2002;  95 733-740
    CrossrefPubMedGoogle Scholar
  • 41 Rydlewicz A, Simpson J A, Taylor R J, Bond C M, Golden M H. The effect of folic acid supplementation on plasma homocysteine in an elderly population.  QJM. 2002;  95 27-35
    CrossrefPubMedGoogle Scholar
  • 42 van Oort F V, Melse-Boonstra A, Brouwer I A et al.. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study.  Am J Clin Nutr. 2003;  77 1318-1323
    PubMedGoogle Scholar
  • 43 Venn B J, Mann J I, Williams S M et al.. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial.  Eur J Clin Nutr. 2002;  56 748-754
    CrossrefPubMedGoogle Scholar
  • 44 Venn B J, Green T J, Moser R, Mann J I. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study.  Am J Clin Nutr. 2003;  77 658-662
    PubMedGoogle Scholar
  • 45 Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women.  Am J Clin Nutr. 2004;  79 473-478
    PubMedGoogle Scholar
  • 46 Carmel R. Cobalamin, the stomach, and aging.  Am J Clin Nutr. 1997;  66 750-759
    PubMedGoogle Scholar
  • 47 Stabler S P, Lindenbaum J, Allen R H. Vitamin B-12 deficiency in the lderly: current dilemmas.  Am J Clin Nutr. 1997;  66 741-749
    PubMedGoogle Scholar
  • 48 Clarke R, Evans G J, Schneede J et al.. Vitamin B12 and folate deficiency in later life.  Age Ageing. 2004;  33 34-41
    CrossrefPubMedGoogle Scholar
  • 49 Refsum H, Smith A D, Ueland P M et al.. Facts and recommendations about total homocysteine determinations: an expert opinion.  Clin Chem. 2004;  50 3-32
    CrossrefPubMedGoogle Scholar
  • 50 Clarke R, Refsum H, Birks J et al.. Screening for vitamin B-12 and folate deficiency in older persons.  Am J Clin Nutr. 2003;  77 1241-1247
    PubMedGoogle Scholar
  • 51 Hvas A M, Juul S, Lauritzen L, Nexo E, Ellegaard J. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study.  J Affect Disord. 2004;  81 269-273
    CrossrefPubMedGoogle Scholar
  • 52 Kuzminski A M, Del Giacco E J, Allen R H, Stabler S P, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin.  Blood. 1998;  92 1191-1198
    PubMedGoogle Scholar
  • 53 Eussen S JPM, de Groot C PGM, Clarke R et al.. Oral vitamin B12 supplementation in elderly people with vitamin B12 deficiency: a dose-finding trial.  Arch Intern Med. , In press
    PubMedGoogle Scholar
  • 54 Seal E C, Metz J, Flicker L, Melny J. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations.  J Am Geriatr Soc. 2002;  50 146-151
    CrossrefPubMedGoogle Scholar
  • 55 McKinley M C, McNulty H, McPartlin J et al.. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete.  Am J Clin Nutr. 2001;  73 759-764
    PubMedGoogle Scholar
  • 56 Ubbink J B, van der Merwe A, Delport R et al.. The effect of a subnormal vitamin B-6 status on homocysteine metabolism.  J Clin Invest. 1996;  98 177-184
    Google Scholar
  • 57 Bosy-Westphal A, Holzapfel A, Czech N, Muller M J. Plasma folate but not vitamin B(12) or homocysteine concentrations are reduced after short-term vitamin B(6) supplementation.  Ann Nutr Metab. 2001;  45 255-258
    PubMedGoogle Scholar
  • 58 Jacques P F, Kalmbach R, Bagley P J et al.. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.  J Nutr. 2002;  132 283-288
    PubMedGoogle Scholar
  • 59 Moat S J, Ashfield-Watt P A, Powers H J, Newcombe R G, McDowell I F. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.  Clin Chem. 2003;  49 295-302
    PubMedGoogle Scholar
  • 60 McKinley M C, McNulty H, McPartlin J, Strain J J, Scott J M. Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status.  Eur J Clin Nutr. 2002;  56 850-856
    CrossrefPubMedGoogle Scholar
  • 61 Mar M H, Zeisel S H. Betaine in wine: answer to the French paradox?.  Med Hypotheses. 1999;  53 383-385
    CrossrefPubMedGoogle Scholar
  • 62 Zeisel S H. Dietary choline: biochemistry, physiology, and pharmacology.  Annu Rev Nutr. 1981;  1 95-121
    CrossrefPubMedGoogle Scholar
  • 63 Canty D J, Zeisel S H. Lecithin and choline in human health and disease.  Nutr Rev. 1994;  52 327-339
    PubMedGoogle Scholar
  • 64 Zeisel S H, Mar M H, Howe J C, Holden J M. Concentrations of choline-containing compounds and betaine in common foods.  J Nutr. 2003;  133 1302-1307
    PubMedGoogle Scholar
  • 65 Holm P I, Bleie Ã, Ueland P M et al.. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation.  Arterioscler Thromb Vasc Biol. 2004;  24 301-307
    PubMedGoogle Scholar
  • 66 Smolin L A, Benevenga N J, Berlow S. The use of betaine for the treatment of homocystinuria.  J Pediatr. 1981;  99 467-472
    PubMedGoogle Scholar
  • 67 Wilcken D E, Wilcken B, Dudman N P, Tyrrell P A. Homocystinuria-the effects of betaine in the treatment of patients not responsive to pyridoxine.  N Engl J Med. 1983;  309 448-453
    PubMedGoogle Scholar
  • 68 Wilcken D E, Dudman N P, Tyrrell P A. Homocystinuria due to cystathionine beta-synthase deficiency-the effects of betaine treatment in pyridoxine-responsive patients.  Metabolism. 1985;  34 1115-1121
    CrossrefPubMedGoogle Scholar
  • 69 Wilcken D E, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment.  J Inherit Metab Dis. 1997;  20 295-300
    PubMedGoogle Scholar
  • 70 Sakura N, Ono H, Nomura S, Ueda H, Fujita N. Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.  J Inherit Metab Dis. 1998;  21 84-85
    CrossrefPubMedGoogle Scholar
  • 71 Singh R H, Kruger W D, Wang L, Pasquali M, Elsas II L J. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria.  Genet Med. 2004;  6 90-95
    PubMedGoogle Scholar
  • 72 Schwab U, Torronen A, Toppinen L et al.. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects.  Am J Clin Nutr. 2002;  76 961-967
    PubMedGoogle Scholar
  • 73 Olthof M R, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women.  J Nutr. 2003;  133 4135-4138
    PubMedGoogle Scholar
  • 74 Steenge G R, Verhoef P, Katan M B. Betaine supplementation lowers plasma homocysteine in healthy men and women.  J Nutr. 2003;  133 1291-1295
    PubMedGoogle Scholar
  • 75 Verhoef P, Stampfer M J, Buring J E et al.. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.  Am J Epidemiol. 1996;  143 845-859
    PubMedGoogle Scholar
  • 76 Mann N J, Li D, Sinclair A J et al.. The effect of diet on plasma homocysteine concentrations in healthy male subjects.  Eur J Clin Nutr. 1999;  53 895-899
    CrossrefPubMedGoogle Scholar
  • 77 Ward M, McNulty H, Pentieva K et al.. Fluctuations in dietary methionine intake do not alter plasma homocysteine concentration in healthy men.  J Nutr. 2000;  130 2653-2657
    PubMedGoogle Scholar
  • 78 Chambers J C, Obeid O A, Kooner J S. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects.  Arterioscler Thromb Vasc Biol. 1999;  19 2922-2927
    CrossrefPubMedGoogle Scholar
  • 79 Chambers J C, McGregor A, Jean M J, Obeid O A, Kooner J S. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.  Circulation. 1999;  99 1156-1160
    PubMedGoogle Scholar
  • 80 Guttormsen A B, Schneede J, Fiskerstrand T, Ueland P M, Refsum H M. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.  J Nutr. 1994;  124 1934-1941
    PubMedGoogle Scholar
  • 81 Verhoef P, Steenge G R, Boelsma E, van Vliet T, Olthof M R, Katan M B. Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized, cross-over trial in humans.  Am J Clin Nutr. 2004;  80 674-679
    PubMedGoogle Scholar
  • 82 Stolzenberg-Solomon R Z, Miller E R, Maguire M G, Selhub J, Appel L J. Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population.  Am J Clin Nutr. 1999;  69 467-475
    PubMedGoogle Scholar
  • 83 Ward M, McNulty H, McPartlin J, Strain J J, Weir D G, Scott J M. Effect of supplemental methionine on plasma homocysteine concentrations in healthy men: a preliminary study.  Int J Vitam Nutr Res. 2001;  71 82-86
    PubMedGoogle Scholar
  • 84 Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hultberg B. The effect of excess daily methionine intake on plasma homocysteine after a methionine loading test in humans.  Clin Chim Acta. 1990;  192 69-76
    CrossrefPubMedGoogle Scholar
  • 85 Haulrik N, Toubro S, Dyerberg J, Stender S, Skov A R, Astrup A. Effect of protein and methionine intakes on plasma homocysteine concentrations: a 6-mo randomized controlled trial in overweight subjects.  Am J Clin Nutr. 2002;  76 1202-1206
    PubMedGoogle Scholar
  • 86 Finkelstein J D, Martin J J, Harris B J. Methionine metabolism in mammals. The methionine-sparing effect of cystine.  J Biol Chem. 1988;  263 11750-11754
    PubMedGoogle Scholar
  • 87 Di Buono M, Wykes L J, Ball R O, Pencharz P B. Dietary cysteine reduces methionine requirement in men.  Am J Clin Nutr. 2001;  74 761-766
    PubMedGoogle Scholar
  • 88 Benevenga N J, Harper A E. Effect of glycine and serine on methionine metabolism in rats fed diets high in methionine.  J Nutr. 1970;  100 1205-1214
    PubMedGoogle Scholar
  • 89 Girard-Globa A, Robin P, Forestier M. Long-term adaptation of weanling rats to high dietary levels of methionine and serine.  J Nutr. 1972;  102 209-217
    PubMedGoogle Scholar
  • 90 Stead L M, Brosnan M E, Brosnan J T. Characterization of homocysteine metabolism in the rat liver.  Biochem J. 2000;  350(Part 3) 685-692
    CrossrefPubMedGoogle Scholar
  • 91 Nygard O, Refsum H, Ueland P M et al.. Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study.  Am J Clin Nutr. 1997;  65 136-143
    PubMedGoogle Scholar
  • 92 Oshaug A, Bugge K H, Refsum H. Diet, an independent determinant for plasma total homocysteine. A cross-sectional study of Norwegian workers on platforms in the North Sea.  Eur J Clin Nutr. 1998;  52 7-11
    CrossrefPubMedGoogle Scholar
  • 93 Nieto F J, Comstock G W, Chambless L E, Malinow R M. Coffee consumption and plasma homocyst(e)ine: results from the Atherosclerosis Risk in Communities Study.  Am J Clin Nutr. 1997;  66 1475-1477
    PubMedGoogle Scholar
  • 94 Grubben M J, Boers G H, Blom H J et al.. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial.  Am J Clin Nutr. 2000;  71 480-484
    PubMedGoogle Scholar
  • 95 Urgert R, van Vliet T, Zock P L, Katan M B. Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers.  Am J Clin Nutr. 2000;  72 1107-1110
    PubMedGoogle Scholar
  • 96 Christensen B, Mosdol A, Retterstol L, Landaas S, Thelle D S. Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol-a randomized controlled trial.  Am J Clin Nutr. 2001;  74 302-307
    PubMedGoogle Scholar
  • 97 Strandhagen E, Landaas S, Thelle D S. Folic acid supplement decreases the homocysteine increasing effect of filtered coffee. A randomised placebo-controlled study.  Eur J Clin Nutr. 2003;  57 1411-1417
    CrossrefPubMedGoogle Scholar
  • 98 Strandhagen E, Zetterberg H, Aires N et al.. The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study.  Int J Mol Med. 2004;  13 811-815
    PubMedGoogle Scholar
  • 99 Verhoef P, Pasman W J, Van Vliet T, Urgert R, Katan M B. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans.  Am J Clin Nutr. 2002;  76 1244-1248
    PubMedGoogle Scholar
  • 100 Olthof M R, Hollman P C, Zock P L, Katan M B. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans.  Am J Clin Nutr. 2001;  73 532-538
    PubMedGoogle Scholar
  • 101 Hodgson J M, Burke V, Beilin L J, Croft K D, Puddey I B. Can black tea influence plasma total homocysteine concentrations?.  Am J Clin Nutr. 2003;  77 907-911
    PubMedGoogle Scholar
  • 102 Ubbink J B, Bissbort S, Vermaak W J, Delport R. Inhibition of pyridoxal kinase by methylxanthines.  Enzyme. 1990;  43 72-79
    PubMedGoogle Scholar
  • 103 Slow S, Lever M, Lee M B, George P M, Chambers S T. Betaine analogues alter homocysteine metabolism in rates.  Int J Biochem Cell Biol. 2004;  36 870-880
    CrossrefPubMedGoogle Scholar
  • 104 Wu X, Skog K, Jagerstad M. Trigonelline, a naturally occurring constituent of green coffee beans behind the mutagenic activity of roasted coffee?.  Mutat Res. 1997;  391 171-177
    PubMedGoogle Scholar
  • 105 Slow S, Miller W E, McGregor D O et al.. Trigonelline is not responsible for the acute increase in plasma homocysteine following ingestion of instant coffee.  Eur J Clin Nutr. 2004;  58 1253-1256
    CrossrefPubMedGoogle Scholar
  • 106 Calvaresi E, Bryan J. B vitamins, cognition, and aging: a review.  J Gerontol B Psychol Sci Soc Sci. 2001;  56 P327-339
    PubMedGoogle Scholar
  • 107 den Heijer T, Vermeer S E, Clarke R et al.. Homocysteine and brain atrophy on MRI of non-demented elderly.  Brain. 2003;  126(Pt 1) 170-175
    PubMedGoogle Scholar
  • 108 Miller A L. The methionine-homocysteine cycle and its effects on cognitive diseases.  Altern Med Rev. 2003;  8 7-19
    PubMedGoogle Scholar
  • 109 van Asselt D Z, Pasman J W, van Lier H J et al.. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons.  J Gerontol A Biol Sci Med Sci. 2001;  56 M775-M779
    PubMedGoogle Scholar
  • 110 Martin D C, Francis J, Protetch J, Huff F J. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study.  J Am Geriatr Soc. 1992;  40 168-172
    CrossrefPubMedGoogle Scholar

 Dr.
Petra Verhoef

Division of Human Nutrition, Bomenweg 2

6703 HD Wageningen, The Netherlands

      >